CTNM insider plans sale of 2,500 common shares

CTNM reports that an affiliate, Morgan Stanley Smith Barney LLC Executive Financial Services, intends to sell 2,500 shares of common stock on NASDAQ on August 3, 2026, in connection with an exercise of stock options for cash.

Rhea-AI Filing Summary

CTNM reports that an affiliate, Morgan Stanley Smith Barney LLC Executive Financial Services, intends to sell 2,500 shares of common stock on NASDAQ on August 3, 2026, in connection with an exercise of stock options for cash. The filing also lists prior sales under a Rule 10b5-1 trading plan for Carmine Stengone, including 2,500 common shares sold on July 8, 2026 for $40,000.00 and 10,000 common shares sold on June 30, 2026 for $160,080.00.

Key Figures

Planned shares to be sold: 2,500 shares Sale proceeds July 8, 2026: $40,000.00 Sale proceeds June 30, 2026: $160,080.00 +2 more

5 metrics

Planned shares to be sold 2,500 shares Common stock sale planned on August 3, 2026 on NASDAQ

Sale proceeds July 8, 2026 $40,000.00 2,500 common shares sold as 10b5-1 Sales for Carmine Stengone

Sale proceeds June 30, 2026 $160,080.00 10,000 common shares sold as 10b5-1 Sales for Carmine Stengone

Shares sold July 8, 2026 2,500 shares Common shares sold under a Rule 10b5-1 sales plan

Shares sold June 30, 2026 10,000 shares Common shares sold under a Rule 10b5-1 sales plan

Key Terms

Form 144, Exercise of Stock Options, Rule 10b5-1, common stock

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"Common | 08/03/2026 | Exercise of Stock Options | Issuer"

Rule 10b5-1 regulatory

"10b5-1 Sales for CARMINE STENGONE 3565 General Atomics Court"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

common stock financial

"10b5-1 Sales for CARMINE STENGONE | Common | 07/08/2026"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CTNM’s Form 144 filing disclose about upcoming stock sales?

The filing discloses an intent to sell 2,500 shares of CTNM common stock on August 3, 2026 on NASDAQ, tied to an exercise of stock options for cash by an affiliated broker-related account.

How many CTNM shares are planned to be sold under this Form 144?

The Form 144 covers a proposed sale of 2,500 shares of CTNM common stock. These shares are associated with an exercise of stock options and are expected to be sold for cash on August 3, 2026.

What prior CTNM stock sales are reported for Carmine Stengone?

The filing lists 2,500 CTNM common shares sold on July 8, 2026 for $40,000.00 and 10,000 shares sold on June 30, 2026 for $160,080.00, both under a Rule 10b5-1 trading plan.

Are the CTNM stock sales made under a Rule 10b5-1 plan?

Yes. The past 3-month activity section notes that CTNM common stock sales for Carmine Stengone on July 8, 2026 and June 30, 2026 were executed as 10b5-1 Sales under a trading plan.

Which security is involved in the CTNM Form 144 filing?

The security involved is common stock of CTNM, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an indicated planned sale of 2,500 shares on August 3, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:20 PM Accepted by SEC EDGAR 08/03/2026 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001861519
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Contineum Therapeutics, Inc.
SEC File Number	001-42001
Address of Issuer	3565 General Atomics Court, Suite 200 San Diego CALIFORNIA 92121
Phone	8583335280
Name of Person for Whose Account the Securities are To Be Sold	CARMINE STENGONE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2500	38725.00	32958632	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/03/2026	Exercise of Stock Options	Issuer			2500	08/03/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CARMINE STENGONE 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	07/08/2026	2500	40000.00
10b5-1 Sales for CARMINE STENGONE 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	06/30/2026	10000	160080.00

144: Remarks and Signature

Remarks
Date of Notice	08/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Carmine Stengone
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)